Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation

Dexmedetomidine (DEX) is an anesthetic that is widely used in the clinic, and it has been reported to exhibit paradoxical effects in the progression of multiple solid tumors. In this study, we sought to explore the mechanism by which DEX regulates hepatocellular carcinoma (HCC) progression underlyin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Exp Mol Med
Auteurs principaux: Chen, Peng, Luo, Xiaojun, Dai, Guanqi, Jiang, Yuchuan, Luo, Yue, Peng, Shuang, Wang, Hao, Xie, Penghui, Qu, Chen, Lin, Wenyu, Hong, Jian, Ning, Xue, Li, Aimin
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8080602/
https://ncbi.nlm.nih.gov/pubmed/32632241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-020-0461-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires